Similar articles
Reuters: Mergers News
Actavis plays IPO card in Ratiopharm battle-sources
FRANKFURT, March 8 (Reuters) - Actavis, the indebted Icelandic generic drugs maker looking to buy German peer Ratiopharm, has raised the prospect of taking the enlarged company public should it win th...